glp 1 drug liraglutide may protect against dementia GLP-1 Long-Term Effects Of GLP-1s: Risks

Learn about the mechanism of action of RYBELSUS (semaglutide) for your adult patients with type 2 diabetes

Henney 2024) demonstrated a potentially meaningful reduction in incident pneumonia with GLP-1 RAs compared with dipeptidyl peptidase-4 (DPP-4) inhibitors (hazard ratio [HR] 0.60, 95% confidence interval [CI] 0.580.62

National Taiwan University researchers highlight the benefits of GLP-1 receptor agonists (GLP-1 RAs) in reducing mortality and severe cardiovascular and renal outcomes for diabetic patients with acute kidney disease (AKD)

Discover clinical trial results and which GLP-1 medication may be right for you.

Although rare, associations with nonarteritic anterior ischemic optic neuropathy, pancreatitis, medullary thyroid carcinoma, and acute kidney injury (AKI) have been reported, primarily through pharmacovigilance and case-based evidence

This is where wellness starts to collide with pharma